Synthesis of HIV Protease Inhibitor ABT-378 (Lopinavir)
- 27 May 2000
- journal article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 4 (4) , 264-269
- https://doi.org/10.1021/op990202j
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Synthesis of ABT-378, an HIV Protease Inhibitor Candidate: Avoiding the Use of Carbodiimides in a Difficult Peptide CouplingOrganic Process Research & Development, 1999
- Reduction of an Enaminone: Synthesis of the Diamino Alcohol Core of RitonavirOrganic Process Research & Development, 1999
- Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency VirusVirology, 1998
- A convenient synthesis of enaminones using tandem acetonitrile condensation, Grignard additionTetrahedron Letters, 1997
- Section Reviews; Anti-infectives: Section Review Anti-infectives: HIV protease inhibitors in early developmentExpert Opinion on Investigational Drugs, 1996
- Current Knowledge and Future Prospects for the Use of HIV Protease InhibitorsDrugs, 1996
- Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)AIDS, 1996
- An Efficient Stereocontrolled Strategy for the Synthesis of Hydroxyethylene Dipeptide IsosteresThe Journal of Organic Chemistry, 1994
- An Efficient Synthesis of (4S)-(-)-4-Isopropyl-2-oxazolidinoneSynthesis, 1989
- The Acidic Dissociation Constants of Phenoxyacetic Acid and its DerivativesJournal of the American Chemical Society, 1943